These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15749277)

  • 21. Use and costs of bariatric surgery and prescription weight-loss medications.
    Encinosa WE; Bernard DM; Steiner CA; Chen CC
    Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
    Collins E; Beattie A; Ramagopalan SV; Pearson-Stuttard J
    J Comp Eff Res; 2024 Jul; 13(7):e240044. PubMed ID: 38808628
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of Slim339 in reducing body weight of overweight and obese human subjects.
    Toromanyan E; Aslanyan G; Amroyan E; Gabrielyan E; Panossian A
    Phytother Res; 2007 Dec; 21(12):1177-81. PubMed ID: 17639559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fighting fat. New drugs against obesity in the pipeline.
    Brower V
    EMBO Rep; 2002 Jul; 3(7):601-3. PubMed ID: 12101089
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug treatment of obesity.
    Bray GA
    Psychiatr Clin North Am; 2005 Mar; 28(1):193-217, ix-x. PubMed ID: 15733619
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug treatment of obesity: present and future].
    Pereira Cunill JL; Garćia-Luna PP
    An Med Interna; 1997 Jun; 14(6):271-4. PubMed ID: 9410096
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy of obesity--from bitter experiences to future possibilities].
    Rössner S
    Lakartidningen; 2000 Apr; 97(14):1726-8. PubMed ID: 10815399
    [No Abstract]   [Full Text] [Related]  

  • 28. [Obesity and health economics. Review and status].
    Pedersen KM; Worre-Jensen AL
    Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A big issue?
    Marnell T
    Br J Gen Pract; 2006 Jan; 56(522):57. PubMed ID: 16438818
    [No Abstract]   [Full Text] [Related]  

  • 30. Another type of intervention: treating obesity with medication.
    Greenway F
    J Am Diet Assoc; 2005 Jun; 105(6):895-8. PubMed ID: 15942538
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges in the discovery and development of new agents for the treatment of obesity.
    Staten MA
    Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Xenical--a modern perspective drug for the treatment of obesity (review)].
    Mkrtumian AM; Biriukova EV
    Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
    [No Abstract]   [Full Text] [Related]  

  • 33. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 34. One pill makes you smaller: the demand for anti-obesity drugs.
    Cawley J; Rizzo JA
    Adv Health Econ Health Serv Res; 2007; 17():149-83. PubMed ID: 19548552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary health care fails when it comes to obesity drug therapy. There is a lack of structured, aimed care].
    Kjellström T
    Lakartidningen; 2010 Mar 31-Apr 13; 107(13-14):895. PubMed ID: 20432861
    [No Abstract]   [Full Text] [Related]  

  • 36. Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
    Fremming BA; Boyd ST
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug discovery: in the eye of the beholder.
    Pearson H
    Nature; 2003 Aug; 424(6952):990-1. PubMed ID: 12944936
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nutritional supplements in overweight and obesity].
    Goebel R; Schulz M
    Pharm Unserer Zeit; 2006; 35(6):522-34. PubMed ID: 17137083
    [No Abstract]   [Full Text] [Related]  

  • 39. Suspense builds on anti-obesity rollercoaster ride.
    Jones D
    Nat Rev Drug Discov; 2011 Jan; 10(1):5-6. PubMed ID: 21193855
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological treatment of obesity and syndrome X].
    Thissen JP
    J Pharm Belg; 2001; 56(2):45-50. PubMed ID: 11396351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.